Search results for Glycogen synthase kinase-3 beta

GSK-3 Beta Monoclonal Antibody, PE-Cy5 Conjugated, Bioss, bsm-33294m-pe-cy5-100ul
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB
Conjugation
PE-Cy5

GSK-3 Beta Monoclonal Antibody, PE-Cy5.5 Conjugated, Bioss, bsm-33294m-pe-Cy5.5-100ul
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB
Conjugation
PE-Cy5.5

GSK-3 Beta Monoclonal Antibody, PE-Cy7 Conjugated, Bioss, bsm-33294m-pe-cy7-100ul
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB
Conjugation
PE-Cy7

GSK-3 Beta Monoclonal Antibody, PerCP Conjugated, Bioss, bsm-33294m-percp-100ul
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB, IF
Conjugation
PerCP

GSK-3 Beta Monoclonal Antibody, PerCP-Cy5.5 Conjugated, Bioss, bsm-33294m-percp-Cy5.5-100ul
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB, IF
Conjugation
PerCP-Cy5.5

GSK-3 Beta Monoclonal Antibody, PerCP-Cy7 Conjugated, Bioss, bsm-33294m-percp-cy7-100ul
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB
Conjugation
PerCP-Cy7

GSK-3 Beta Monoclonal Antibody, RBITC Conjugated, Bioss, bsm-33294m-rbitc-100ul
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB, IF
Conjugation
RBITC

GSK3 beta Antibody (YA744), MedChemexpress, HY-P80698
GSK3 beta Antibody (YA744) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to GSK3 beta.
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB, IHC-P, FC
Conjugation
Non-conjugated
Phospho-GSK3 beta (Ser9) Antibody (YA193), MedChemexpress, HY-P80820
Phospho-GSK3 beta (Ser9) Antibody (YA193) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-GSK3 beta (Ser9).
Host
Rabbit
Reactivity
Human, Mouse, Rat
Applications
WB, IHC-F, IHC-P, ICC/IF
Conjugation
Non-conjugated

GSK-3 beta Polyclonal Antibody, Bioss, bs-0023M
Host
Mouse
Reactivity
Human, Mouse, Rat
Applications
WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC)
Conjugation
Unconjugated
Please provide the required information below so that we can quickly source your products.
